I've seen some methods whereby centrifugation resulted in samples that were 90% pure by GC (gas chromotagraphy) or HPLC (high performance liquid chromatography), but this would be considered 'crude' extracts. Surely the company's involvement on the pharmaceutical/nutraceutical side would provide them enough wet chemistry methods to determine what's needed. Could use some form of chemical/liquid-liquid extraction followed by preparatory chromatography, but would expect them to have laboratory analytical capability using either GC/HPLC for quantification. Also supercritical fluid extraction, a researcher in my facility uses that for oils, but I'm not that familiar with that in practical application.
A nice, in-house, minimally-equipped analytical support lab would likely run $0.5 mill-$1 mill minimum for equipment with technical support personnel on the order of $60-100k salary.
Don't laugh, but I know several professors who equipped entire labs with about ~$1 mill worth of equipment for only $50-100k by getting the stuff off Ebay....amazing how little CEO's of bankrupt biotech company's will offer expensive equipment when they are taking space in their garage, lol. I was even tempted to buy something I didn't even need just because it was so cheap, right out of the box not even used.
Look at this baby for $7k (nothing to do with FITX/Cannabis), dirt cheap...can't touch it direct from manufacture at that price:
actually they do - as they can continually issue new shares and no one can stop them. Most pennystock do EXACTLY that - for years and years. Pennystocks are basically ATM machines for insiders. and they have no problem using them.
Market Data 
Markets 
AI
